New Report on Global Intravenous Access Devices Industry 2017 at Market Research Nest

MarketResearchNest.com adds “Global Intravenous Access Devices Market 2017-2021” new report to its research database. The report spread across 105 pages with table and figures in it.
Research analysts forecast the global intravenous access devices market to grow at a CAGR of 5.22% during the period 2017-2021.

About Intravenous Access Devices
Intravenous access devices can be inserted into peripheral or central veins for the administration of fluids and nutritional compounds (hyperalimentation); delivery of medications such as antibiotics, chemotherapy drugs, and other intravenous drugs; blood transfusions; and blood collection for diagnostic purpose. Vascular access is one of the essential components of patient care in both hospitals and ambulatory care centers. Intravenous access devices are most commonly used for administration of fluids and nutritional compounds, delivery of medications, blood transfusions, and blood collection for diagnostic purpose. Intravenous access devices are thin tubes made of medical grade materials such as plastic, silicone rubber, polyvinyl chloride (PVC), and nylon. Various intravenous access devices are available, which can be inserted peripherally or centrally, for the safe and reliable venous access in daily clinical practice.

Covered in this report
The report covers the present scenario and the growth prospects of the global intravenous access devices market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of intravenous access devices.

Browse full table of contents and data tables at https://www.marketresearchnest.com/global-intravenous-access-devices-market-2017-2021.html

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio's report, Global Intravenous Access Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Technavio recognizes the following companies as the key players in the global intravenous access devices market: B. Braun Melsungen, BD, C. R. Bard, Smiths Medical, and TERUMO CORPORATION

Other Prominent Vendors in the market are: AngioDynamics, APEXMED International, Baxter, Cook Medical, Delta Med, EXELINT International, Fresenius, GaltNeedleTech, Global Medikit, Hospira, ICU Medical, Medtronic, NIPRO Medical, Promed Group, RenovoRx, Retractable Technologies, Teleflex, Vigmed, and Vygon.

Commenting on the report, an analyst from Research team said: “The latest trend gaining momentum in the market is Rise in popularity of antimicrobial-coated CIVCs. Intravenous access devices are essential for providing fluids, medications, and intravenous nutrition. They are also used to provide cancer treatment to patients. Intravenous access devices such as CIVCs are longer and reach deeper into the major veins of the body. They provide secure and durable intravenous access. However, CRBSIs and thrombosis are common in patients with CVCs. They have a significant impact on the market. This includes increasing healthcare expenses and morbidity and mortality in hospitalized patients.

Order a Purchase Report Copy at https://www.marketresearchnest.com/purchase.php?reportid=285074

According to the report, one of the major drivers for this market is Increase in number of hospitalizations. The number of hospitalizations is increasing across the world. This is due to the growth of the global population and the increasing prevalence of various acute and chronic diseases. In the US, the total number of inpatient hospitalizations increased by 15% from 31.7 million in 2000 to 36.5 million in 2012. According to the CDC, in 2014, there were 141.4 million emergency department visits that resulted in 11.2 million hospital admissions and 1.8 million critical care unit admissions in the US. In 2014, about 20 million people visited physicians' offices for cancer as the primary diagnosis, 17.8 million people visited physicians' offices and 3.9 million people visited hospital outpatient departments due to infectious and parasitic diseases in the US. According to the CDC, in 2015, 4.9 million adults were diagnosed with kidney diseases in the US.

Further, the report states that one of the major factors hindering the growth of this market is Complications associated with intravenous access devices. Intravenous access devices such as intravenous catheters are found to be the most common sources of bacteremia and fungemia. Intravenous catheters predispose the patient to the risks of local and systemic infections such as CRBSIs, septic thrombophlebitis, endocarditis, and other metastatic infections such as lung abscess, brain abscess, osteomyelitis, and endophthalmitis. Infiltration, phlebitis, and dislodgement are the three most common mechanical complications associated with intravenous catheters.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Enquiry before Buying at https://www.marketresearchnest.com/enquirybuy.php?reportid=285074

About:
MarketResearchNest.com is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the world’s most complete and recent database of expert insights on industries, organizations, products, and trends.

Contact
Mr. Jeet Jain
Sales Manager
sales@marketresearchnest.com
+1-240-284-8070(U.S)
+44-20-3290-4151(U.K)
Connect with us: Google+ | LinkedIn | Twitter | Facebook

Contact
Mr. Jeet Jain
Sales Manager
sales@marketresearchnest.com
+1-240-284-8070(U.S)
+44-20-3290-4151(U.K)
Connect with us: Google+ | LinkedIn | Twitter | Facebook

This release was published on openPR.